Skull-base osteomyelitis: Fungal vs. bacterial infection

Clinical Microbiology and Infection

Volumn 17, Issue 2, 2011, Pages 306-311

  Blyth, C C ^a,b   Gomes, L ^a   Sorrell, T C ^a,c   Da Cruz, M ^a   Sud, A ^d   Chen, S C A ^a,c  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d NEPEAN HOSPITAL   (Australia)

Author keywords

Bacterial; Fungi; Osteomyelitis; Skull base

Indexed keywords

ADALIMUMAB; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CEFTAZIDIME; CIPROFLOXACIN; CORTICOSTEROID; METHOTREXATE; POSACONAZOLE; TIMENTIN; VANCOMYCIN;

ACINETOBACTER; ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; ASPERGILLUS; BACTERIAL INFECTION; BONE BIOPSY; CHRONIC SINUSITIS; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CRANIAL NERVE PARALYSIS; DEBRIDEMENT; DIABETES MELLITUS; DISEASE ASSOCIATION; EXTERNAL OTITIS; FACE EDEMA; FEMALE; HEARING IMPAIRMENT; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; MALE; MORTALITY; MYCOSIS; OSTEOMYELITIS; OTALGIA; OVERALL SURVIVAL; PERIORBITAL EDEMA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RHINORRHEA; SCEDOSPORIUM APIOSPERMUM; SINUS PAIN; SKULL BASE OSTEOMYELITIS; SKULL BASED OSTEOMYELITIS; ZYGOMYCETES;

BACTERIA (MICROORGANISMS); FUNGI; PSEUDOMONAS AERUGINOSA;

EID: 78751612463     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03231.x     Document Type: Article

References (25)

1. Meltzer PE, Kelemen G. Pyocyaneous osteomyelitis of the temporal bone, mandible and zygoma. Laryngoscope 1959; 69: 1300-1316.
2. Chandler JR. Malignant external otitis. Laryngoscope 1968; 78: 1257-1294.
3. Lee S, Hooper R, Fuller A, Turlakow A, Cousins V, Nouraei R. Otogenic cranial base osteomyelitis: a proposed prognosis-based system for disease classification. Otol Neurotol 2008; 29: 666-672.
4. Sreepada GS, Kwartler JA. Skull base osteomyelitis secondary to malignant otitis externa. Curr Opin Otolaryngol Head Neck Surg 2003; 11: 316-323.
5. Chandler JR. Malignant external otitis and osteomyelitis of the base of the skull. Am J Otol 1989; 10: 108-110.
6. Chen CN, Chen YS, Yeh TH, Hsu CJ, Tseng FY. Outcomes of malignant external otitis: survival vs mortality. Acta Otolaryngol 2009; 22: 1-6.
7. Kountakis S, Kemper JV, Chang J, DiMaio DJM, Stiernberg CM. Osteomyelitis of the base of the skull secondary to Aspergillus. Am J Otolaryngol 1997; 18: 19-22.
8. Malone DG, O'Boynick PL, Ziegler DK, Batnitsky S, Hubble JP, Holladay FP. Osteomyelitis of the skull base. Neurosurgery 1992; 30: 426-431.
9. Rothholtz VS, Lee AD, Shamloo B, Bazargan M, Pan D, Djalilian HR. Skull base osteomyelitis: the effect of comorbid disease on hospitalization. Laryngoscope 2008; 118: 1917-1924.
10. Shelton JC, Antonelli PJ, Hackett R. Skull base fungal osteomyelitis in an immunocompetent host. Otolaryngol Head Neck Surg 2002; 126: 76-78.
11. Singh A, Al Khabori M, Hyder J. Skull base osteomyelitis: diagnostic and therapeutic challenges in atypical presentation. Otolaryngol Head Neck Surg 2005; 133: 121-125.
12. Stodulski D, Kowalska B, Stankiewicz C. Otogenic skull base osteomyelitis caused by invasive fungal infection. Eur Arch Otorhinolaryngol 2006; 263: 1070-1076.
13. Grobman LR, Ganz W, Casiano R, Goldberg S. Atypical osteomyelitis of the skull base. Laryngoscope 1989; 99(7 Pt 1): 671-676.
14. Magliulo G, Varacalli S, Ciofalo A. Osteomyelitis of the skull base with atypical onset and evolution. Ann Otol Rhinol Laryngol 2000; 109: 326-330.
15. Cunningham M, Yu VL, Turner J, Curtin H. Necrotizing otitis externa due to Aspergillus in an immunocompetent patient. Arch Otolaryngol Head Neck Surg 1988; 114: 554-556.
16. Rubin J, Yu VL. Malignant external otitis: insights into pathogenesis, clincial manifestations, diagnosis and therapy. Am J Med 1988; 85: 391-398.
17. Chan LL, Singh S, Jones D, Diaz EM, Ginsberg JE. Imaging of mucormycosis skull base osteomyelitis. AJNR Am J Neuroradiol 2000; 21: 828-831.
18. National centre for classification of health. International statistical classification of diseases and related problems. 10th edn, Australian Modification, 4th edn. Sydney:Faculty of Health Science, The University of Sydney, 2004.
19. Mani N, Sudhoff H, Rajagopal S, Moffat D, Axon PR. Cranial nerve involvement in malignant external otitis: implications for clinical outcome. Laryngoscope 2007; 117: 907-910.
20. Rubin Grandis J, Branstetter BFI, Yu VL. The changing face of malignant (necrotising external otitis): clinical, radiological, and anatomic correlations. Lancet Infect Dis 2004; 4: 34-39.
21. Roden MM, Zaoutis TE, Buchanan WL et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634-653.
22. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909-917.
23. Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 2008; 47: 503-509.
24. Parkins MD, Sabuda DM, Elsayed S, Laupland KB. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 2007; 60: 613-618.
25. Carfrae MJ, Kesser BW. Malignant otitis externa. Otolaryngol Clin North Am 2008; 41: 537-549.